RadNet, Inc.

RDNT

US7504911022

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
58.64 ^USD	-0.39%		+0.17%	+68.65%

May. 15	Truist Securities Adjusts Price Target on RadNet to $63 From $55, Maintains Buy Rating	MT
May. 15	Transcript : RadNet, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 03:00 PM

RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022

November 09, 2022 at 06:00 am EST

RadNet, Inc. provided earnings guidance for the full year of 2022. Revenue – Imaging Ctr Operations is expected $1,360 million to $1,410 million.

Latest news about RadNet, Inc.

Truist Securities Adjusts Price Target on RadNet to $63 From $55, Maintains Buy Rating	May. 15	MT
Transcript : RadNet, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 03:00 PM	May. 14
RadNet, Inc. Revises Earnings Guidance for the Year 2024	May. 13	CI
Transcript : RadNet, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
RadNet Swings to Q1 Adjusted Earnings, Revenue Rises	May. 09	MT
Earnings Flash (RDNT) RADNET Reports Q1 Revenue $431.7M	May. 08	MT
Earnings Flash (RDNT) RADNET Posts Q1 EPS $0.07	May. 08	MT
RadNet, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08	CI
RadNet Closes Term Loan, Revolving Credit Facility Refinancing Transaction	Apr. 18	MT
RadNet, Inc. Announces Closing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction	Apr. 18	CI
RadNet Prices, Upsizes Term Loan, Revolving Credit Facility Refinancing Transaction	Apr. 11	MT
RadNet, Inc. Announces Pricing and Upsizing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing Transaction	Apr. 11	CI
RadNet to Buy Six More Imaging Centers in Houston	Apr. 10	MT
RadNet, Inc. signed a definitive agreement to acquire Assets of six imaging centers in Houston, Texas.	Apr. 09	CI
RadNet, Inc. Announces Proposed Refinancing of Its Term Loan and Revolving Credit Facility	Apr. 03	CI
RadNet Sets Up Southern California Radiology Joint Venture With Providence Health System	Apr. 02	MT
RadNet Announces Outpatient Radiology Partnership with Providence Health System to Include Seven Centers in Burbank, Santa Clarita and the Northern San Fernando Valley of Los Angeles	Apr. 02	CI
Truist Securities Raises Price Target on RadNet to $55 From $51, Maintains Buy Rating	Mar. 28	MT
RadNet Closes $230.2 Million Offering	Mar. 12	MT
RadNet Prices $200 Million Underwritten Public Offering; Shares Fall	Mar. 08	MT
RadNet Plans $200 Million Underwritten Public Stock Offering; Shares Slump After Hours	Mar. 07	MT
Barclays Starts Coverage on RadNet With Equalweight Rating, $48 Price Target	Mar. 06	MT
Truist Securities Adjusts RadNet Price Target to $51 From $42, Maintains Buy Rating	Mar. 04	MT
RadNet Surge After Q4 Adjusted Net Income, Revenue Rise	Mar. 01	MT
Transcript : RadNet, Inc., Q4 2023 Earnings Call, Mar 01, 2024	Mar. 01

RadNet, Inc. is a national provider of fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States. It has a network of 366 owned and/or operated outpatient imaging centers. The Companyâs Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Companyâs Artificial Intelligence (AI) segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate and pulmonary diagnostics. The Company, through its joint ventured Arizona Diagnostic Radiology Group, LLC, owns seven outpatient imaging centers.

Sector

Healthcare Facilities & Services

Calendar

2024-06-12 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for RadNet, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

58.64 USD

Average target price

58.33 USD

Spread / Average Target

-0.52%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
RADNET, INC.	+68.65%	4.33B
SONIC HEALTHCARE LIMITED	-24.16%	7.76B
SYNLAB AG	-2.98%	2.64B
DR. LAL PATHLABS LIMITED	+2.72%	2.63B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-46.17%	2.16B
NEOGENOMICS, INC.	-15.27%	1.75B
FLEURY S.A.	-22.12%	1.46B
METROPOLIS HEALTHCARE LIMITED	+13.62%	1.17B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-43.81%	1.14B
VIJAYA DIAGNOSTIC CENTRE LIMITED	+20.41%	999M

Medical & Diagnostic Laboratories

RadNet, Inc.

Equities

RDNT

US7504911022

Healthcare Facilities & Services

RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022

Latest news about RadNet, Inc.

Chart RadNet, Inc.

Company Profile

Income Statement Evolution

Ratings for RadNet, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical & Diagnostic Laboratories